Biophytis Sa Quick Ratio (BPTS) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Biophytis Sa  (NASDAQ: BPTS)

Biophytis Sa's Quick Ratio

BPTS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2023, Quick Ratio deteriorated to 0.45 a new company low.

Within Major Pharmaceutical Preparations industry 410 other companies have achieved higher Quick Ratio than Biophytis Sa in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 1972 to 2571.

Explain Quick Ratio?
How much Cash & cash equivalents BPTS´s has?
What are BPTS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BPTS Quick Ratio (Dec 31 2023)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2022)
Q4
Y / Y Current Liabilities Change -33.09 % -56.95 % -46.57 % -46.57 % -20.15 %
Y / Y Cash & cash equivalent Change -47.27 % -76.73 % -76.73 % -76.73 % -55.87 %
Quick Ratio MRQ 0.45 0.45 0.45 0.45 0.57
BPTS's Total Ranking # 2571 # 1972 # 1972 # 1985 #
Seq. Current Liabilities Change 0 % 0 % 0 % -33.09 % -35.65 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -47.27 % -55.87 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 411
Healthcare Sector # 773
Overall Market # 2571


Quick Ratio Statistics
High Average Low
1.03 0.74 0.45
(Dec 31 2021)   (Dec 31 2023)




Financial Statements
Biophytis Sa's Current Liabilities $ 14 Millions Visit BPTS's Balance sheet
Biophytis Sa's Cash & cash equivalent $ 6 Millions Visit BPTS's Balance sheet
Source of BPTS's Sales Visit BPTS's Sales by Geography


Cumulative Biophytis Sa's Quick Ratio

BPTS's Quick Ratio for the trailling 12 Months

BPTS Quick Ratio

 (Dec 31 2023)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -47.09 % -43.38 % -23.85 % -9.88 % 36.2 %
Y / Y Cash & cash equivalent TTM Growth -72.95 % -71.52 % -41.64 % 5.59 % 124.57 %
Quick Ratio TTM 0.45 0.49 0.63 0.77 0.88
Total Ranking TTM # 3999 # 3342 # 3963 # 2965 #
Seq. Current Liabilities TTM Growth -11 % -22.74 % -13.03 % -11.53 % -4.75 %
Seq. Cash & cash equivalent TTM Growth -18.31 % -40.25 % -28.7 % -22.3 % -13.97 %

Quick ratio ranking by company, industry and sector >> Back to BPTS Financial Strength Comparisons >> Go to Compare BPTS Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in BPTS's Current Liabilities to $13.85 millions, cumulative Quick Ratio to 0.45 below the BPTS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 486 other companies have achieved higher Quick Ratio than Biophytis Sa. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3342 to 3999.

Explain Quick Ratio?
How much Cash & cash equivalents BPTS´s has?
What are BPTS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 487
Healthcare Sector # 991
Within the Market # 3999


trailing twelve months Quick Ratio Statistics
High Average Low
1.03 0.79 0.45
(Dec 31 2021)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Q32 Bio Inc   1.20 $ 25.617  Millions$ 21.336  Millions
Gridai Technologies Corp  1.18 $ 3.712  Millions$ 3.133  Millions
Scisparc Ltd  1.18 $ 2.076  Millions$ 1.756  Millions
Clever Leaves Holdings Inc   1.18 $ 6.831  Millions$ 5.811  Millions
Harrow Inc   1.16 $ 82.766  Millions$ 71.297  Millions
Kyntra Bio Inc   1.16 $ 203.451  Millions$ 175.582  Millions
Amphastar Pharmaceuticals Inc   1.15 $ 259.006  Millions$ 225.407  Millions
Quantum Cyber N v   1.14 $ 14.142  Millions$ 12.421  Millions
Cartesian Therapeutics Inc   1.13 $ 76.911  Millions$ 68.209  Millions
Azitra Inc   1.12 $ 1.796  Millions$ 1.603  Millions
Petros Pharmaceuticals inc   1.12 $ 13.300  Millions$ 11.880  Millions
Cytomx Therapeutics Inc   1.12 $ 174.509  Millions$ 155.913  Millions
Lifevantage Corp  1.10 $ 21.605  Millions$ 19.609  Millions
Virpax Pharmaceuticals Inc   1.08 $ 9.142  Millions$ 8.437  Millions
Wave Life Sciences Ltd   1.07 $ 200.351  Millions$ 186.440  Millions
Nature s Sunshine Products inc   1.07 $ 82.373  Millions$ 76.753  Millions
Akari Therapeutics Plc  1.07 $ 3.845  Millions$ 3.599  Millions
Calliditas Therapeutics Ab  1.04 $ 104.676  Millions$ 100.997  Millions
Elite Pharmaceuticals Inc   1.00 $ 7.853  Millions$ 7.834  Millions
Stablecoin Development Corporation  1.00 $ 3.130  Millions$ 3.141  Millions
Enveric Biosciences Inc   0.99 $ 2.288  Millions$ 2.318  Millions
Inflarx N V  0.98 $ 18.547  Millions$ 18.866  Millions
Tuhura Biosciences Inc   0.98 $ 3.665  Millions$ 3.737  Millions
Indivior Pharmaceuticals Inc   0.97 $ 1,146.000  Millions$ 1,181.000  Millions
Durect Corp  0.96 $ 29.680  Millions$ 31.044  Millions
Jazz Pharmaceuticals Plc  0.93 $ 1,506.310  Millions$ 1,624.312  Millions
Elicio Therapeutics Inc   0.93 $ 12.894  Millions$ 13.907  Millions
Zevra Therapeutics Inc   0.92 $ 67.737  Millions$ 73.720  Millions
Reshape Lifesciences Inc  0.91 $ 4.459  Millions$ 4.890  Millions
Vtv Therapeutics Inc   0.91 $ 9.511  Millions$ 10.433  Millions

Date modified: 2026-09-02T19:26:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.